GoodRX appoints Wendy Barnes as CEO; shares rise

GoodRx Holdings

16/12/2024 21:32

** GoodRX  GDRX.O  shares rise 1.3% to $4.65 after the bell
    ** Co appoints Wendy Barnes as president and chief executive
officer effective January 1, 2025
    ** Barnes previously held the position of CEO at RxBenefits 
    ** As CEO, Wendy will focus on bringing all brand
affordability programs onto the GoodRx platform, expanding
GoodRx's product experience with healthcare professionals and
enriching partnerships with retail pharmacies, insurers and
pharmaceutical manufacturers - GDRX
    ** Barnes replaces Scott Wagner, who was the interim CEO at
the company, appointed in April 2023
    ** 9 of 18 brokerages rate the stock "buy" or higher, 8
"hold" and 1 "sell"; their median PT is $7
    ** YTD, GDRX down 31.4%

 (Reporting by Abhinav Parmar in Bengaluru)
 ((Abhinav.parmar@thomsonreuters.com))